808e9326-1751-4154-a778-cefeca685554/5-0
00:00:03.344 --> 00:00:06.470
fan of Endeavor Health.
He is the Associate Chief Science Officer.
808e9326-1751-4154-a778-cefeca685554/5-1
00:00:06.470 --> 00:00:08.664
Brian,
thank you so much for joining us today.
808e9326-1751-4154-a778-cefeca685554/6-0
00:00:09.304 --> 00:00:10.744
Thank you for inviting me.
808e9326-1751-4154-a778-cefeca685554/8-0
00:00:11.304 --> 00:00:15.319
So for those who don't know,
Endeavor Health is a health system based
808e9326-1751-4154-a778-cefeca685554/8-1
00:00:15.319 --> 00:00:18.876
in Evanston, Illinois,
just outside of Chicago, with about 2,
808e9326-1751-4154-a778-cefeca685554/8-2
00:00:18.876 --> 00:00:23.179
000 hospital beds across 9 hospitals
served by 10,000 providers. So Brian,
808e9326-1751-4154-a778-cefeca685554/8-3
00:00:23.179 --> 00:00:27.883
as the Associate Chief Science Officer,
I'm sure you have a lot of things on your
808e9326-1751-4154-a778-cefeca685554/8-4
00:00:27.883 --> 00:00:30.636
plate.
Today we're going to talk about clinical
808e9326-1751-4154-a778-cefeca685554/8-5
00:00:30.636 --> 00:00:31.784
trials, specifically
808e9326-1751-4154-a778-cefeca685554/9-0
00:00:32.344 --> 00:00:37.038
how you're working to improve access to
clinical trials and the latest treatments
808e9326-1751-4154-a778-cefeca685554/9-1
00:00:37.038 --> 00:00:41.561
outside of major medical centers in major
cities. So I'll hand it over to you.
808e9326-1751-4154-a778-cefeca685554/9-2
00:00:41.561 --> 00:00:44.824
What's going on with clinical trials at
Endeavor Health?
808e9326-1751-4154-a778-cefeca685554/10-0
00:00:45.904 --> 00:00:52.613
Yeah, so we're in a really unique area.
And I think our issues are uniform really
808e9326-1751-4154-a778-cefeca685554/10-1
00:00:52.613 --> 00:00:58.340
throughout a lot of the country.
We're in Chicago, it's a major city.
808e9326-1751-4154-a778-cefeca685554/10-2
00:00:58.340 --> 00:01:04.885
We are part of eight different academic
institutions in Chicago. And, you know,
808e9326-1751-4154-a778-cefeca685554/10-3
00:01:04.885 --> 00:01:09.304
it's finding our footprint and remaining
competitive.
808e9326-1751-4154-a778-cefeca685554/12-0
00:01:10.264 --> 00:01:16.514
We personally are part of a large network
that, you know, as you said,
808e9326-1751-4154-a778-cefeca685554/12-1
00:01:16.514 --> 00:01:22.853
we have 9 hospitals in our system.
We continue to expand. We service 4.
808e9326-1751-4154-a778-cefeca685554/12-2
00:01:22.853 --> 00:01:28.047
1 million patients.
And so how do you keep patients in the
808e9326-1751-4154-a778-cefeca685554/12-3
00:01:28.047 --> 00:01:28.664
system?
808e9326-1751-4154-a778-cefeca685554/13-0
00:01:29.064 --> 00:01:36.584
How do you use clinical trials as one of
those main attractions that not only
808e9326-1751-4154-a778-cefeca685554/14-0
00:01:38.104 --> 00:01:42.739
gives the care that I think patients
deserve, but also, you know,
808e9326-1751-4154-a778-cefeca685554/14-1
00:01:42.739 --> 00:01:47.865
attracts patients and from a, you know,
kind of a business minded sense,
808e9326-1751-4154-a778-cefeca685554/14-2
00:01:47.865 --> 00:01:53.624
how are we retaining that and not losing
those patients to other sites where they
808e9326-1751-4154-a778-cefeca685554/14-3
00:01:53.624 --> 00:01:56.784
believe may have different trials,
different
808e9326-1751-4154-a778-cefeca685554/15-0
00:01:56.904 --> 00:02:02.522
you know, technologies, et cetera.
So that's really where clinical trial
808e9326-1751-4154-a778-cefeca685554/15-1
00:02:02.522 --> 00:02:02.984
space.
808e9326-1751-4154-a778-cefeca685554/16-0
00:02:04.624 --> 00:02:10.472
is we want to and certainly have proven
ourselves that we have the ability to
808e9326-1751-4154-a778-cefeca685554/16-1
00:02:10.472 --> 00:02:15.570
offer clinical trials of latest,
greatest care to on top of already
808e9326-1751-4154-a778-cefeca685554/16-2
00:02:15.570 --> 00:02:19.544
outstanding care throughout a large
hospital system.
808e9326-1751-4154-a778-cefeca685554/17-0
00:02:20.424 --> 00:02:23.379
Got it.
So let's go with a concrete use case,
808e9326-1751-4154-a778-cefeca685554/17-1
00:02:23.379 --> 00:02:28.775
if you wouldn't mind. Walking us through.
Now, I don't want to put you on the spot,
808e9326-1751-4154-a778-cefeca685554/17-2
00:02:28.775 --> 00:02:32.950
so I'll give you a choice.
Either patient Jayne has some kind of
808e9326-1751-4154-a778-cefeca685554/17-3
00:02:32.950 --> 00:02:37.640
condition and the only treatment
available for this maybe orphan disease
808e9326-1751-4154-a778-cefeca685554/17-4
00:02:37.640 --> 00:02:41.944
is through a clinical trial being offered
through Endeavor Health.
808e9326-1751-4154-a778-cefeca685554/18-0
00:02:42.304 --> 00:02:46.992
That might be a good place to start.
Or starting in the story of how Endeavor
808e9326-1751-4154-a778-cefeca685554/18-1
00:02:46.992 --> 00:02:51.921
Health is leveraging clinical trials to
improve access and maintain market share.
808e9326-1751-4154-a778-cefeca685554/18-2
00:02:51.921 --> 00:02:53.304
Leave it in your hands.
808e9326-1751-4154-a778-cefeca685554/19-0
00:02:54.104 --> 00:02:59.211
Yeah, I think both,
we can talk about both of those because I
808e9326-1751-4154-a778-cefeca685554/19-1
00:02:59.211 --> 00:03:04.648
think they're both very relevant.
You know, I do think, you know,
808e9326-1751-4154-a778-cefeca685554/19-2
00:03:04.648 --> 00:03:09.673
we have 10,000 providers.
Most of us are fellowship trained,
808e9326-1751-4154-a778-cefeca685554/19-3
00:03:09.673 --> 00:03:14.616
really top of the game,
have believed that the best care is
808e9326-1751-4154-a778-cefeca685554/19-4
00:03:14.616 --> 00:03:16.264
constantly evolving.
808e9326-1751-4154-a778-cefeca685554/20-0
00:03:16.744 --> 00:03:20.546
And as you start really pushing that
envelope, you know,
808e9326-1751-4154-a778-cefeca685554/20-1
00:03:20.546 --> 00:03:23.815
you move quickly into that clinical trial
space,
808e9326-1751-4154-a778-cefeca685554/20-2
00:03:23.815 --> 00:03:28.819
because that's really going to test and
offer the latest cares. Sometimes,
808e9326-1751-4154-a778-cefeca685554/20-3
00:03:28.819 --> 00:03:32.888
as you brought up,
as compassionate care in certain oncology
808e9326-1751-4154-a778-cefeca685554/20-4
00:03:32.888 --> 00:03:35.624
cases, which I'll give you an example of,
808e9326-1751-4154-a778-cefeca685554/21-0
00:03:36.824 --> 00:03:39.795
to give access to treatments that,
you know,
808e9326-1751-4154-a778-cefeca685554/21-1
00:03:39.795 --> 00:03:43.955
patients would not otherwise have access
to. And so, you know,
808e9326-1751-4154-a778-cefeca685554/21-2
00:03:43.955 --> 00:03:48.577
even in a real world example,
and certainly trials that I have either
808e9326-1751-4154-a778-cefeca685554/21-3
00:03:48.577 --> 00:03:53.132
witnessed or have been part of,
cancer trials are the lowest hanging
808e9326-1751-4154-a778-cefeca685554/21-4
00:03:53.132 --> 00:03:56.104
fruit there because they're the most
common.
808e9326-1751-4154-a778-cefeca685554/22-0
00:03:56.184 --> 00:04:02.005
common because of that space is always
pushing to hopefully stomp out cancer one
808e9326-1751-4154-a778-cefeca685554/22-1
00:04:02.005 --> 00:04:05.958
day. But also,
whether I'm talking about cancer trials
808e9326-1751-4154-a778-cefeca685554/22-2
00:04:05.958 --> 00:04:09.624
or I'm talking about other even benign
conditions,
808e9326-1751-4154-a778-cefeca685554/23-0
00:04:10.664 --> 00:04:15.576
ranging from psychiatry to ophthalmology
to urology.
808e9326-1751-4154-a778-cefeca685554/23-1
00:04:15.576 --> 00:04:20.118
There are so many clinical trials in that
space.
808e9326-1751-4154-a778-cefeca685554/23-2
00:04:20.118 --> 00:04:27.069
But if you're going to use a concrete
example, and specifically, you know,
808e9326-1751-4154-a778-cefeca685554/23-3
00:04:27.069 --> 00:04:31.704
you have a patient,
he's a 74 year old gentleman,
808e9326-1751-4154-a778-cefeca685554/24-0
00:04:32.104 --> 00:04:39.097
who has a advanced prostate cancer. And,
you know, he has gone through for many,
808e9326-1751-4154-a778-cefeca685554/24-1
00:04:39.097 --> 00:04:45.917
many years a lot of the traditional
therapies that have involved testosterone,
808e9326-1751-4154-a778-cefeca685554/24-2
00:04:45.917 --> 00:04:51.184
wiping agents out.
And once you go through so many different
808e9326-1751-4154-a778-cefeca685554/26-0
00:04:51.304 --> 00:04:54.962
you know, treatments,
you kind of come to an end.
808e9326-1751-4154-a778-cefeca685554/26-1
00:04:54.962 --> 00:05:00.157
There's not a lot of new things that you
can offer. And as an example,
808e9326-1751-4154-a778-cefeca685554/25-0
00:04:57.104 --> 00:04:57.584
Mhm.
808e9326-1751-4154-a778-cefeca685554/26-2
00:05:00.157 --> 00:05:06.083
he was offered a clinical trial to look
at several different things. Number one,
808e9326-1751-4154-a778-cefeca685554/26-3
00:05:06.083 --> 00:05:11.864
he was able to get the most advanced
imaging. So that is on trial to say, hey,
808e9326-1751-4154-a778-cefeca685554/27-0
00:05:12.184 --> 00:05:16.706
we can locate that tumor with the latest,
greatest, you know,
808e9326-1751-4154-a778-cefeca685554/27-1
00:05:16.706 --> 00:05:21.738
kind of radio tracers in that field and
really localize that cancer.
808e9326-1751-4154-a778-cefeca685554/27-2
00:05:21.738 --> 00:05:26.041
And because it's a new radiotherapy or
imaging technology,
808e9326-1751-4154-a778-cefeca685554/27-3
00:05:26.041 --> 00:05:31.730
you can really leverage that to really
localize that where the disease is and
808e9326-1751-4154-a778-cefeca685554/27-4
00:05:31.730 --> 00:05:35.304
hopefully come up with treatments based
on that.
808e9326-1751-4154-a778-cefeca685554/28-0
00:05:35.784 --> 00:05:41.260
And then he was so happy with that result.
And based on that radio tracer,
808e9326-1751-4154-a778-cefeca685554/28-1
00:05:41.260 --> 00:05:46.810
he was actually able to enroll in a
different trial that tagged a radiation
808e9326-1751-4154-a778-cefeca685554/28-2
00:05:46.810 --> 00:05:51.921
therapy to that imaging agent.
So that would target and localize that
808e9326-1751-4154-a778-cefeca685554/28-3
00:05:51.921 --> 00:05:56.667
treatment that much better.
And so that's the kind of thing that
808e9326-1751-4154-a778-cefeca685554/28-4
00:05:56.667 --> 00:05:57.544
we're really
808e9326-1751-4154-a778-cefeca685554/29-0
00:05:57.864 --> 00:06:02.591
aiming for is to say that, hey,
these are not standard of care,
808e9326-1751-4154-a778-cefeca685554/29-1
00:06:02.591 --> 00:06:08.206
but all of the trials that we enroll
patients in have that ability to offer
808e9326-1751-4154-a778-cefeca685554/29-2
00:06:08.206 --> 00:06:13.155
benefits to that patient,
even though that they're not widely used
808e9326-1751-4154-a778-cefeca685554/29-3
00:06:13.155 --> 00:06:16.184
or certainly in guidelines at that point.
808e9326-1751-4154-a778-cefeca685554/30-0
00:06:16.904 --> 00:06:18.984
But it, but it improves the.
808e9326-1751-4154-a778-cefeca685554/31-0
00:06:19.944 --> 00:06:25.130
patient care and access,
and certainly the quality of care that
808e9326-1751-4154-a778-cefeca685554/31-1
00:06:25.130 --> 00:06:26.184
patients get.
808e9326-1751-4154-a778-cefeca685554/32-0
00:06:27.064 --> 00:06:30.995
So other than joining podcasts like this
one,
808e9326-1751-4154-a778-cefeca685554/32-1
00:06:30.995 --> 00:06:37.747
you mentioned that clinical trial of the
kind you just described help increase
808e9326-1751-4154-a778-cefeca685554/32-2
00:06:37.747 --> 00:06:42.961
patient enrollment.
How is Endeavor leveraging its abilities
808e9326-1751-4154-a778-cefeca685554/32-3
00:06:42.961 --> 00:06:47.064
to identify the appropriate clinical
trials for
808e9326-1751-4154-a778-cefeca685554/33-0
00:06:48.024 --> 00:06:52.589
for eligible populations in order to
increase patient enrollment and general
808e9326-1751-4154-a778-cefeca685554/33-1
00:06:52.589 --> 00:06:56.087
market share. Of course,
I guess the market share would be
808e9326-1751-4154-a778-cefeca685554/33-2
00:06:56.087 --> 00:07:00.771
primarily for the target sick populations,
but if there's any kind of tertiary
808e9326-1751-4154-a778-cefeca685554/33-3
00:07:00.771 --> 00:07:04.744
benefits to well populations,
that might also be worth mentioning.
808e9326-1751-4154-a778-cefeca685554/34-0
00:07:05.984 --> 00:07:08.504
Yeah, so I mean, I, we...
808e9326-1751-4154-a778-cefeca685554/36-0
00:07:09.584 --> 00:07:13.804
Endeavor Health has changed names
throughout time,
808e9326-1751-4154-a778-cefeca685554/36-1
00:07:13.804 --> 00:07:20.424
but historically was Evanston Healthcare,
a much smaller operation back over 20
808e9326-1751-4154-a778-cefeca685554/36-2
00:07:20.424 --> 00:07:24.562
years ago.
But it was one of the first systems to
808e9326-1751-4154-a778-cefeca685554/35-0
00:07:22.864 --> 00:07:23.464
Mhm.
808e9326-1751-4154-a778-cefeca685554/36-3
00:07:24.562 --> 00:07:30.024
employ an electronic health record system
or EHR system. In fact,
808e9326-1751-4154-a778-cefeca685554/38-0
00:07:30.104 --> 00:07:35.784
We were the beta testing site for the
most common thing known as Epic.
808e9326-1751-4154-a778-cefeca685554/38-1
00:07:35.784 --> 00:07:40.984
And so Epic has evolved and certainly we
have data on, you know,
808e9326-1751-4154-a778-cefeca685554/38-2
00:07:40.984 --> 00:07:46.184
millions of patients for over 20 years.
And as that has evolved,
808e9326-1751-4154-a778-cefeca685554/37-0
00:07:44.584 --> 00:07:44.744
Mm.
808e9326-1751-4154-a778-cefeca685554/38-3
00:07:46.184 --> 00:07:52.824
we have been forward thinking to say, hey,
we want to be able to overlay different
808e9326-1751-4154-a778-cefeca685554/38-4
00:07:52.824 --> 00:07:53.624
electronic
808e9326-1751-4154-a778-cefeca685554/39-0
00:07:54.304 --> 00:08:01.300
programs so that we can quickly search
patients for eligibility in clinical
808e9326-1751-4154-a778-cefeca685554/39-1
00:08:01.300 --> 00:08:07.652
trials and to enhance and identify those
patients who would qualify.
808e9326-1751-4154-a778-cefeca685554/39-2
00:08:07.652 --> 00:08:12.624
So we have that ability to look at one of
the largest
808e9326-1751-4154-a778-cefeca685554/41-0
00:08:12.904 --> 00:08:19.224
healthcare systems in the country and
really quickly identify patients.
808e9326-1751-4154-a778-cefeca685554/41-1
00:08:19.224 --> 00:08:25.280
And that's pertinent because a lot of
trials can benefit the masses,
808e9326-1751-4154-a778-cefeca685554/41-2
00:08:25.280 --> 00:08:31.864
but there are certain trials that are
really designed for rare conditions.
808e9326-1751-4154-a778-cefeca685554/42-0
00:08:32.184 --> 00:08:37.605
And so one of those issues has been that
we haven't been able to identify those
808e9326-1751-4154-a778-cefeca685554/40-0
00:08:32.784 --> 00:08:32.984
Mm.
808e9326-1751-4154-a778-cefeca685554/42-1
00:08:37.605 --> 00:08:41.671
patients historically,
but with these type of technologies,
808e9326-1751-4154-a778-cefeca685554/42-2
00:08:41.671 --> 00:08:46.957
we're identifying those patients with the
rare conditions and getting them in
808e9326-1751-4154-a778-cefeca685554/42-3
00:08:46.957 --> 00:08:48.584
trials or offering them.
808e9326-1751-4154-a778-cefeca685554/43-0
00:08:47.944 --> 00:08:52.418
Just to jump in for one second, Brian,
because I want to clarify so our
808e9326-1751-4154-a778-cefeca685554/43-1
00:08:52.418 --> 00:08:56.396
listeners understand.
You're saying that maybe there's only 50,
808e9326-1751-4154-a778-cefeca685554/43-2
00:08:56.396 --> 00:09:00.746
000 Americans with condition Y,
and maybe they're not all in Chicago,
808e9326-1751-4154-a778-cefeca685554/43-3
00:09:00.746 --> 00:09:03.543
maybe some are in Texas or Maine or
Florida,
808e9326-1751-4154-a778-cefeca685554/43-4
00:09:03.543 --> 00:09:06.464
and it just so happens that the
biotherapeutic
808e9326-1751-4154-a778-cefeca685554/44-0
00:09:06.624 --> 00:09:11.987
intervention that would treat condition Y
is being offered through Endeavor and
808e9326-1751-4154-a778-cefeca685554/44-1
00:09:11.987 --> 00:09:15.608
nowhere else,
how do you find these patients that are
808e9326-1751-4154-a778-cefeca685554/44-2
00:09:15.608 --> 00:09:21.173
not Endeavor patients but are across the
country and bring them in to enroll them?
808e9326-1751-4154-a778-cefeca685554/44-3
00:09:21.173 --> 00:09:25.464
Because in order to get approval by the
FDA, you need a certain
808e9326-1751-4154-a778-cefeca685554/45-0
00:09:25.544 --> 00:09:29.235
kind of amount of participation and
you're needing to identify these patients.
808e9326-1751-4154-a778-cefeca685554/45-1
00:09:29.235 --> 00:09:30.824
Is that what you're talking about?
808e9326-1751-4154-a778-cefeca685554/46-0
00:09:31.384 --> 00:09:36.298
Yeah, I mean, it goes both ways.
It goes locally, right? Because we have 4.
808e9326-1751-4154-a778-cefeca685554/46-1
00:09:36.298 --> 00:09:41.665
1 million patients to now in our data set
to query on an annual basis and look for
808e9326-1751-4154-a778-cefeca685554/46-2
00:09:41.665 --> 00:09:46.774
people who would qualify for, you know,
rare conditions and common conditions.
808e9326-1751-4154-a778-cefeca685554/46-3
00:09:46.774 --> 00:09:51.624
But we also have partnered through many
different organizations, networks,
808e9326-1751-4154-a778-cefeca685554/47-0
00:09:51.824 --> 00:09:56.900
but they're all electronically linked to
a help identify patients, you know,
808e9326-1751-4154-a778-cefeca685554/47-1
00:09:56.900 --> 00:10:00.461
kind of quicker.
And a lot of this is really when you
808e9326-1751-4154-a778-cefeca685554/47-2
00:10:00.461 --> 00:10:01.384
start looking.
808e9326-1751-4154-a778-cefeca685554/48-0
00:10:01.664 --> 00:10:01.864
Um...
808e9326-1751-4154-a778-cefeca685554/50-0
00:10:03.624 --> 00:10:08.799
in this type of space is in the oncology
realm, the neuroscience realm,
808e9326-1751-4154-a778-cefeca685554/50-1
00:10:08.799 --> 00:10:14.261
where a lot of the conditions and
treatments may be more rare. So it again,
808e9326-1751-4154-a778-cefeca685554/50-2
00:10:14.261 --> 00:10:20.011
has the ability to look nationwide to
look for eligible patients. But you know,
808e9326-1751-4154-a778-cefeca685554/49-0
00:10:16.944 --> 00:10:17.544
Mhm.
808e9326-1751-4154-a778-cefeca685554/50-3
00:10:20.011 --> 00:10:22.024
a lot of this is also posted
808e9326-1751-4154-a778-cefeca685554/53-0
00:10:22.904 --> 00:10:29.354
on trial sites and government sites to
make people aware and practitioners aware.
808e9326-1751-4154-a778-cefeca685554/53-1
00:10:29.354 --> 00:10:35.175
But really, especially internally,
when certain conditions are being met,
808e9326-1751-4154-a778-cefeca685554/53-2
00:10:35.175 --> 00:10:41.389
there will be flags that pop up that can
help identify those patients and make
808e9326-1751-4154-a778-cefeca685554/52-0
00:10:35.944 --> 00:10:36.424
Mhm.
808e9326-1751-4154-a778-cefeca685554/53-3
00:10:41.389 --> 00:10:41.704
them
808e9326-1751-4154-a778-cefeca685554/55-0
00:10:41.864 --> 00:10:45.112
provider,
the current person who's taking care of
808e9326-1751-4154-a778-cefeca685554/55-1
00:10:45.112 --> 00:10:48.231
that patient aware, so that they can,
you know,
808e9326-1751-4154-a778-cefeca685554/54-0
00:10:46.064 --> 00:10:46.544
Mmh.
808e9326-1751-4154-a778-cefeca685554/55-2
00:10:48.231 --> 00:10:52.584
refer to that trial or at least get that
patient more information.
808e9326-1751-4154-a778-cefeca685554/56-0
00:10:53.064 --> 00:10:57.056
So obviously,
Epic Care Everywhere is one way to try to
808e9326-1751-4154-a778-cefeca685554/56-1
00:10:57.056 --> 00:11:00.976
access different instances of Epic across
the country.
808e9326-1751-4154-a778-cefeca685554/56-2
00:11:00.976 --> 00:11:06.394
Does Endeavor leverage connectivity to
national networks in order to try to
808e9326-1751-4154-a778-cefeca685554/56-3
00:11:06.394 --> 00:11:12.026
identify patients with certain diagnoses
codes that might be eligible for this
808e9326-1751-4154-a778-cefeca685554/56-4
00:11:12.026 --> 00:11:13.024
sort of trial?
808e9326-1751-4154-a778-cefeca685554/57-0
00:11:14.264 --> 00:11:18.546
A lot is in motion.
So nationally becomes a little bit more
808e9326-1751-4154-a778-cefeca685554/57-1
00:11:18.546 --> 00:11:23.186
of a problem, if you will,
just because of HIPAA and things like
808e9326-1751-4154-a778-cefeca685554/57-2
00:11:23.186 --> 00:11:28.325
that. But really through the connectivity,
whether that's through Epic,
808e9326-1751-4154-a778-cefeca685554/57-3
00:11:28.325 --> 00:11:33.464
whether that's through, you know,
kind of organizations, whether that's
808e9326-1751-4154-a778-cefeca685554/60-0
00:11:33.664 --> 00:11:39.777
the American Cancer Society, the NIH,
all of that, we are part of all of those,
808e9326-1751-4154-a778-cefeca685554/60-1
00:11:39.777 --> 00:11:44.744
you know, kind of trials.
And certainly the awareness of that is
808e9326-1751-4154-a778-cefeca685554/60-2
00:11:44.744 --> 00:11:50.552
made possible through that. You know,
I think we have a much higher success
808e9326-1751-4154-a778-cefeca685554/58-0
00:11:47.064 --> 00:11:47.624
Mmh.
808e9326-1751-4154-a778-cefeca685554/60-3
00:11:50.552 --> 00:11:54.984
rate because when you control the
dialogue in the system,
808e9326-1751-4154-a778-cefeca685554/59-0
00:11:55.264 --> 00:11:55.864
Mhm.
808e9326-1751-4154-a778-cefeca685554/61-0
00:11:55.704 --> 00:11:59.263
It makes people more aware.
And so while nationally,
808e9326-1751-4154-a778-cefeca685554/61-1
00:11:59.263 --> 00:12:03.695
there's a huge presence,
and certainly we have patients coming in
808e9326-1751-4154-a778-cefeca685554/61-2
00:12:03.695 --> 00:12:08.127
all the time from other parts of the
country for clinical trials,
808e9326-1751-4154-a778-cefeca685554/61-3
00:12:08.127 --> 00:12:11.551
certainly the identification,
if just being frank,
808e9326-1751-4154-a778-cefeca685554/61-4
00:12:11.551 --> 00:12:16.722
is currently still emphasized within our
own expanded network throughout the
808e9326-1751-4154-a778-cefeca685554/61-5
00:12:16.722 --> 00:12:17.864
Chicagoland area.
808e9326-1751-4154-a778-cefeca685554/62-0
00:12:18.824 --> 00:12:22.680
So, it's my understanding, Brian,
that in 2025,
808e9326-1751-4154-a778-cefeca685554/62-1
00:12:22.680 --> 00:12:28.705
Endeavor Health had 550 active trials
across multiple specialties and 2300
808e9326-1751-4154-a778-cefeca685554/62-2
00:12:28.705 --> 00:12:34.329
clinical trial patients that were
enrolled in those trials last year.
808e9326-1751-4154-a778-cefeca685554/62-3
00:12:34.329 --> 00:12:37.864
Given the complexity and the vast volume
of
808e9326-1751-4154-a778-cefeca685554/63-0
00:12:38.024 --> 00:12:43.228
patients and trials and details,
I imagine that there's a lot of data to
808e9326-1751-4154-a778-cefeca685554/63-1
00:12:43.228 --> 00:12:46.366
orchestrate.
Are there any data challenges?
808e9326-1751-4154-a778-cefeca685554/63-2
00:12:46.366 --> 00:12:51.071
I'm asking this, of course,
because this is Healthy Data podcast.
808e9326-1751-4154-a778-cefeca685554/63-3
00:12:51.071 --> 00:12:56.490
Are there any data challenges associated
with managing such a vast array of
808e9326-1751-4154-a778-cefeca685554/63-4
00:12:56.490 --> 00:12:58.344
differing data sources and
808e9326-1751-4154-a778-cefeca685554/64-0
00:12:58.904 --> 00:13:00.184
Problems you're trying to address.
808e9326-1751-4154-a778-cefeca685554/65-0
00:13:01.224 --> 00:13:06.040
Yeah, so, you know, the amount of data,
these are big data, you know, issues.
808e9326-1751-4154-a778-cefeca685554/65-1
00:13:06.040 --> 00:13:10.980
And that's awesome because what you're
really reflecting on is that we have the
808e9326-1751-4154-a778-cefeca685554/65-2
00:13:10.980 --> 00:13:14.129
ability,
whether we're talking about genetic data,
808e9326-1751-4154-a778-cefeca685554/65-3
00:13:14.129 --> 00:13:17.278
whether we're talking about large
population data,
808e9326-1751-4154-a778-cefeca685554/65-4
00:13:17.278 --> 00:13:22.032
and all of the imaging and all the lab
work and all the patient demographics
808e9326-1751-4154-a778-cefeca685554/65-5
00:13:22.032 --> 00:13:23.144
that go into that,
808e9326-1751-4154-a778-cefeca685554/66-0
00:13:23.504 --> 00:13:27.798
This is big data there.
For every patient in a trial,
808e9326-1751-4154-a778-cefeca685554/66-1
00:13:27.798 --> 00:13:33.762
we estimate that there's over a million
data points that we are constantly
808e9326-1751-4154-a778-cefeca685554/66-2
00:13:33.762 --> 00:13:40.441
collecting. And that may even be a small,
you know, data, you know, clinical trial.
808e9326-1751-4154-a778-cefeca685554/66-3
00:13:40.441 --> 00:13:43.304
So, you know, that requires a lot of
808e9326-1751-4154-a778-cefeca685554/67-0
00:13:43.344 --> 00:13:48.090
backup of data,
and that requires a lot of secure servers,
808e9326-1751-4154-a778-cefeca685554/67-1
00:13:48.090 --> 00:13:53.077
especially in today's era,
where we're always concerned about
808e9326-1751-4154-a778-cefeca685554/67-2
00:13:53.077 --> 00:13:58.547
information and protection at all points.
And so we have, you know,
808e9326-1751-4154-a778-cefeca685554/67-3
00:13:58.547 --> 00:14:04.741
certainly huge servers that are all,
you know, kind of constantly monitored.
808e9326-1751-4154-a778-cefeca685554/67-4
00:14:04.741 --> 00:14:05.144
And I
808e9326-1751-4154-a778-cefeca685554/69-0
00:14:05.624 --> 00:14:11.166
Don't know the details of it,
because I joke that our system is very
808e9326-1751-4154-a778-cefeca685554/69-1
00:14:11.166 --> 00:14:17.754
much like Fort Knox. It's very hard to,
you know, kind of compromise that system.
808e9326-1751-4154-a778-cefeca685554/69-2
00:14:17.754 --> 00:14:23.296
But certainly all of the necessary
systems are in place, the clouds,
808e9326-1751-4154-a778-cefeca685554/69-3
00:14:23.296 --> 00:14:25.064
to really gather that.
808e9326-1751-4154-a778-cefeca685554/68-0
00:14:23.624 --> 00:14:24.104
Mhm.
808e9326-1751-4154-a778-cefeca685554/70-0
00:14:25.144 --> 00:14:25.504
Data.
808e9326-1751-4154-a778-cefeca685554/71-0
00:14:26.344 --> 00:14:31.263
Right. You know, it's another topic,
and I guess leveraging the last few
808e9326-1751-4154-a778-cefeca685554/71-1
00:14:31.263 --> 00:14:35.373
minutes of this podcast,
I know that one of your goals is to
808e9326-1751-4154-a778-cefeca685554/71-2
00:14:35.373 --> 00:14:39.416
increase access to clinical trials
outside of major cities.
808e9326-1751-4154-a778-cefeca685554/71-3
00:14:39.416 --> 00:14:43.526
So outside of Chicago,
you're trying to look to get a larger
808e9326-1751-4154-a778-cefeca685554/71-4
00:14:43.526 --> 00:14:47.434
catchment area.
You're looking to reduce barriers to care
808e9326-1751-4154-a778-cefeca685554/71-5
00:14:47.434 --> 00:14:47.704
with
808e9326-1751-4154-a778-cefeca685554/72-0
00:14:47.824 --> 00:14:53.863
transportation or hotels or food and
expand the footprint of Endeavor beyond
808e9326-1751-4154-a778-cefeca685554/72-1
00:14:53.863 --> 00:14:59.197
the immediate Chicago area.
Can you elaborate on what you're trying
808e9326-1751-4154-a778-cefeca685554/72-2
00:14:59.197 --> 00:15:04.373
to do and how data may,
kind of what new data sources or what new
808e9326-1751-4154-a778-cefeca685554/72-3
00:15:04.373 --> 00:15:05.864
data challenges are
808e9326-1751-4154-a778-cefeca685554/73-0
00:15:07.064 --> 00:15:09.464
related to those initiatives.
808e9326-1751-4154-a778-cefeca685554/74-0
00:15:10.824 --> 00:15:15.205
So in a classic model,
and something that we initially had to
808e9326-1751-4154-a778-cefeca685554/74-1
00:15:15.205 --> 00:15:18.597
overcome,
is that if you have a clinical trial,
808e9326-1751-4154-a778-cefeca685554/74-2
00:15:18.597 --> 00:15:21.777
you have that patient come into your
clinic,
808e9326-1751-4154-a778-cefeca685554/74-3
00:15:21.777 --> 00:15:26.300
they often have to come in multiple times
throughout the study.
808e9326-1751-4154-a778-cefeca685554/74-4
00:15:26.300 --> 00:15:29.904
You have to have labs drawn, evaluated,
et cetera.
808e9326-1751-4154-a778-cefeca685554/76-0
00:15:30.184 --> 00:15:35.286
And so that for a lot of patients was a
barrier because that just travel time
808e9326-1751-4154-a778-cefeca685554/76-1
00:15:35.286 --> 00:15:40.127
alone, people didn't want to, you know,
sign up for trials because it was
808e9326-1751-4154-a778-cefeca685554/76-2
00:15:40.127 --> 00:15:44.641
considered a burden. And so, you know,
certainly locally into the 4.
808e9326-1751-4154-a778-cefeca685554/76-3
00:15:44.641 --> 00:15:49.352
1 million lives that we serve,
that we've overcome that because we have
808e9326-1751-4154-a778-cefeca685554/75-0
00:15:46.824 --> 00:15:47.384
Okay.
808e9326-1751-4154-a778-cefeca685554/76-4
00:15:49.352 --> 00:15:50.464
so many different
808e9326-1751-4154-a778-cefeca685554/79-0
00:15:50.664 --> 00:15:54.089
you know,
locations throughout a large system where
808e9326-1751-4154-a778-cefeca685554/79-1
00:15:54.089 --> 00:15:58.238
patients can enroll.
So even if you live in X part of Chicago,
808e9326-1751-4154-a778-cefeca685554/79-2
00:15:58.238 --> 00:16:03.442
there's likely a clinical trial center
part of Endeavor Health that, you know,
808e9326-1751-4154-a778-cefeca685554/77-0
00:16:01.784 --> 00:16:01.944
Mm.
808e9326-1751-4154-a778-cefeca685554/79-3
00:16:03.442 --> 00:16:08.382
you can go to to get your labs or to get
you be seen evaluated, et cetera.
808e9326-1751-4154-a778-cefeca685554/78-0
00:16:06.104 --> 00:16:06.384
And.
808e9326-1751-4154-a778-cefeca685554/79-4
00:16:08.382 --> 00:16:09.304
And certainly,
808e9326-1751-4154-a778-cefeca685554/81-0
00:16:09.464 --> 00:16:13.311
Most of the trials will be offered,
you know, throughout, you know,
808e9326-1751-4154-a778-cefeca685554/81-1
00:16:13.311 --> 00:16:16.932
the entire system. So again,
that improves access just based on
808e9326-1751-4154-a778-cefeca685554/81-2
00:16:16.932 --> 00:16:20.270
location, et cetera.
But then we're also forward thinking.
808e9326-1751-4154-a778-cefeca685554/80-0
00:16:19.704 --> 00:16:19.904
Yeah.
808e9326-1751-4154-a778-cefeca685554/81-3
00:16:20.270 --> 00:16:23.438
And as you said,
is that our goal is that it's not only
808e9326-1751-4154-a778-cefeca685554/81-4
00:16:23.438 --> 00:16:27.512
just serving the lives that we see
immediately in the Chicagoland area,
808e9326-1751-4154-a778-cefeca685554/81-5
00:16:27.512 --> 00:16:30.624
but it's how do we serve a greater good
throughout the
808e9326-1751-4154-a778-cefeca685554/82-0
00:16:31.944 --> 00:16:36.267
the country as well.
And so if patients are, you know,
808e9326-1751-4154-a778-cefeca685554/82-1
00:16:36.267 --> 00:16:41.927
identified and you're on the East Coast,
so in Maryland or in New York,
808e9326-1751-4154-a778-cefeca685554/82-2
00:16:41.927 --> 00:16:48.452
and they want to be part of a trial here,
is that possible? And the answer is yes,
808e9326-1751-4154-a778-cefeca685554/82-3
00:16:48.452 --> 00:16:54.584
because in the era of telemedicine,
in the era of so much virtual healthcare,
808e9326-1751-4154-a778-cefeca685554/83-0
00:16:54.904 --> 00:17:00.895
that a lot of things that we can do can
be done as certainly as a follow-up or,
808e9326-1751-4154-a778-cefeca685554/83-1
00:17:00.895 --> 00:17:07.035
you know, at great distances away. Now,
the exception for that would be if you're
808e9326-1751-4154-a778-cefeca685554/83-2
00:17:07.035 --> 00:17:12.278
getting a drug delivered or something
that actually requires multiple
808e9326-1751-4154-a778-cefeca685554/83-3
00:17:12.278 --> 00:17:14.824
interventions and stuff like that.
808e9326-1751-4154-a778-cefeca685554/85-0
00:17:14.904 --> 00:17:18.257
A lot of times,
you have to come in town for that,
808e9326-1751-4154-a778-cefeca685554/85-1
00:17:18.257 --> 00:17:23.714
and there's no way to overcome that part.
But certainly, if it's a national trial,
808e9326-1751-4154-a778-cefeca685554/84-0
00:17:20.424 --> 00:17:20.904
Mmh.
808e9326-1751-4154-a778-cefeca685554/85-2
00:17:23.714 --> 00:17:27.133
we'll help identify a center that may be,
you know,
808e9326-1751-4154-a778-cefeca685554/85-3
00:17:27.133 --> 00:17:31.144
closer that can give you that in that
setting, trial center.
808e9326-1751-4154-a778-cefeca685554/86-0
00:17:31.944 --> 00:17:37.982
So if you were in a patient in New York
and you were identified and needed to
808e9326-1751-4154-a778-cefeca685554/86-1
00:17:37.982 --> 00:17:41.465
participate in an Endeavor trial in
Chicago,
808e9326-1751-4154-a778-cefeca685554/86-2
00:17:41.465 --> 00:17:47.580
would it be possible for that patient in
New York to have labs or imaging done
808e9326-1751-4154-a778-cefeca685554/86-3
00:17:47.580 --> 00:17:51.064
remotely and then have those samples
shipped
808e9326-1751-4154-a778-cefeca685554/87-0
00:17:51.224 --> 00:17:52.504
to Chicago.
808e9326-1751-4154-a778-cefeca685554/89-0
00:17:53.504 --> 00:17:58.444
So it's not a uniform yes,
because certain clinical trials depends
808e9326-1751-4154-a778-cefeca685554/89-1
00:17:58.444 --> 00:18:03.532
on the sponsor or the type of trial
you're doing, may not permit it.
808e9326-1751-4154-a778-cefeca685554/88-0
00:18:01.384 --> 00:18:01.864
Mhm.
808e9326-1751-4154-a778-cefeca685554/89-2
00:18:03.532 --> 00:18:08.251
But for the most part,
that scenario that you described is very
808e9326-1751-4154-a778-cefeca685554/89-3
00:18:08.251 --> 00:18:11.864
possible and frequently done at Endeavor
Health.
808e9326-1751-4154-a778-cefeca685554/92-0
00:18:12.104 --> 00:18:15.082
So again,
our goal is to provide that care no
808e9326-1751-4154-a778-cefeca685554/92-1
00:18:15.082 --> 00:18:20.586
matter where you are and that top quality.
So if it's easier and you so happen to be
808e9326-1751-4154-a778-cefeca685554/90-0
00:18:16.504 --> 00:18:17.024
Mhm.
808e9326-1751-4154-a778-cefeca685554/92-2
00:18:20.586 --> 00:18:23.823
in New York,
you can certainly get local imaging,
808e9326-1751-4154-a778-cefeca685554/92-3
00:18:23.823 --> 00:18:27.643
local labs done,
send over that and overcome that for most
808e9326-1751-4154-a778-cefeca685554/92-4
00:18:27.643 --> 00:18:31.464
trials. And again,
some of this is just dependent on that.
808e9326-1751-4154-a778-cefeca685554/91-0
00:18:29.464 --> 00:18:30.024
Tong.
808e9326-1751-4154-a778-cefeca685554/93-0
00:18:32.504 --> 00:18:37.367
How much of an outlier is Endeavor
compared to other health systems across
808e9326-1751-4154-a778-cefeca685554/93-1
00:18:37.367 --> 00:18:41.648
the country is becoming a,
it sounds like Endeavor is positioning
808e9326-1751-4154-a778-cefeca685554/93-2
00:18:41.648 --> 00:18:46.576
itself to at least try to become a
national destination center for clinical
808e9326-1751-4154-a778-cefeca685554/93-3
00:18:46.576 --> 00:18:50.467
trial excellence.
Is this kind of common or uncommon as you
808e9326-1751-4154-a778-cefeca685554/93-4
00:18:50.467 --> 00:18:52.024
try to gain market share
808e9326-1751-4154-a778-cefeca685554/94-0
00:18:52.824 --> 00:18:57.704
far beyond the immediate kind of
geographic area of your health system.
808e9326-1751-4154-a778-cefeca685554/95-0
00:18:58.624 --> 00:19:02.471
So, I think it is an uncommon goal.
I mean,
808e9326-1751-4154-a778-cefeca685554/95-1
00:19:02.471 --> 00:19:08.504
I think a lot of places in the country,
you know, are really just...
808e9326-1751-4154-a778-cefeca685554/96-0
00:19:09.704 --> 00:19:14.406
They're not as interested in, you know,
providing cutting edge care.
808e9326-1751-4154-a778-cefeca685554/96-1
00:19:14.406 --> 00:19:19.722
They're kind of happy with the standard
and they will adopt practices as they
808e9326-1751-4154-a778-cefeca685554/96-2
00:19:19.722 --> 00:19:24.016
become more routine.
I think our positioning is we really want
808e9326-1751-4154-a778-cefeca685554/96-3
00:19:24.016 --> 00:19:29.263
to offer really the cutting edge,
outstanding, you know, care on top of the,
808e9326-1751-4154-a778-cefeca685554/96-4
00:19:29.263 --> 00:19:32.467
you know,
on top of the great care that people
808e9326-1751-4154-a778-cefeca685554/96-5
00:19:32.467 --> 00:19:32.944
already
808e9326-1751-4154-a778-cefeca685554/98-0
00:19:33.224 --> 00:19:36.908
receive here.
And so I think that as a primary
808e9326-1751-4154-a778-cefeca685554/98-1
00:19:36.908 --> 00:19:41.377
motivation, it distinguishes us.
I think our nimbleness,
808e9326-1751-4154-a778-cefeca685554/98-2
00:19:41.377 --> 00:19:46.394
and one of the things I didn't really
talk about was, you know,
808e9326-1751-4154-a778-cefeca685554/98-3
00:19:46.394 --> 00:19:52.744
what things are we doing to facilitate
the process? One of the things that we do
808e9326-1751-4154-a778-cefeca685554/97-0
00:19:50.664 --> 00:19:51.144
Mhm.
808e9326-1751-4154-a778-cefeca685554/99-0
00:19:52.904 --> 00:19:58.275
in research, no matter where you are,
is we kind of hurt ourselves because you
808e9326-1751-4154-a778-cefeca685554/99-1
00:19:58.275 --> 00:20:03.102
want a trial. Let's say I'm at, you know,
the classic academic center.
808e9326-1751-4154-a778-cefeca685554/99-2
00:20:03.102 --> 00:20:07.861
It usually takes over a year to get a
clinical trial approved at your
808e9326-1751-4154-a778-cefeca685554/99-3
00:20:07.861 --> 00:20:12.960
institution. And that's, you know,
through the institutional review board,
808e9326-1751-4154-a778-cefeca685554/99-4
00:20:12.960 --> 00:20:14.184
the study reviews.
808e9326-1751-4154-a778-cefeca685554/100-0
00:20:14.344 --> 00:20:17.729
before that's actually up and going.
And by that time,
808e9326-1751-4154-a778-cefeca685554/100-1
00:20:17.729 --> 00:20:20.438
a lot of people have already passed you
up.
808e9326-1751-4154-a778-cefeca685554/100-2
00:20:20.438 --> 00:20:25.055
And a lot of times you've already missed
a lot of patients that could have
808e9326-1751-4154-a778-cefeca685554/100-3
00:20:25.055 --> 00:20:29.549
benefited from that. So as an example,
our goal is that by the time you,
808e9326-1751-4154-a778-cefeca685554/100-4
00:20:29.549 --> 00:20:33.304
a physician investigator says, hey,
I want to start a study,
808e9326-1751-4154-a778-cefeca685554/102-0
00:20:33.704 --> 00:20:38.478
We want to have that up and rolling
within 30 days. It is,
808e9326-1751-4154-a778-cefeca685554/102-1
00:20:38.478 --> 00:20:43.737
it's an aggressive goal.
I think if we want to become really the
808e9326-1751-4154-a778-cefeca685554/102-2
00:20:43.737 --> 00:20:47.864
leading trial and, you know,
translational science
808e9326-1751-4154-a778-cefeca685554/103-0
00:20:49.704 --> 00:20:53.339
destination in the country.
That's what we're going to really have to
808e9326-1751-4154-a778-cefeca685554/103-1
00:20:53.339 --> 00:20:56.144
do to be looked at and viewed as a
preferred partner.
808e9326-1751-4154-a778-cefeca685554/104-0
00:20:57.144 --> 00:21:00.521
So, Brian,
we are approaching the end of this
808e9326-1751-4154-a778-cefeca685554/104-1
00:21:00.521 --> 00:21:04.413
podcast episode.
I'd like to ask you a kind of broad
808e9326-1751-4154-a778-cefeca685554/104-2
00:21:04.413 --> 00:21:08.084
concluding question. Endeavor wants to,
you know,
808e9326-1751-4154-a778-cefeca685554/104-3
00:21:08.084 --> 00:21:12.930
start a clinical trial and have it up and
rolling within 30 days.
808e9326-1751-4154-a778-cefeca685554/104-4
00:21:12.930 --> 00:21:18.584
You potentially have an entire nation
full of possible future clinical trial
808e9326-1751-4154-a778-cefeca685554/106-0
00:21:18.904 --> 00:21:24.701
participants who may be getting lab
specimens or imaging drawn or done
808e9326-1751-4154-a778-cefeca685554/106-1
00:21:24.701 --> 00:21:30.417
remotely across the United States from
non-endeavor health providers.
808e9326-1751-4154-a778-cefeca685554/106-2
00:21:30.417 --> 00:21:36.786
You're having lots of different data
sources and a very ambitious timeline to
808e9326-1751-4154-a778-cefeca685554/106-3
00:21:36.786 --> 00:21:38.664
reconcile all this data
808e9326-1751-4154-a778-cefeca685554/107-0
00:21:39.144 --> 00:21:44.063
From a data perspective, you know,
what advice do you give to other health
808e9326-1751-4154-a778-cefeca685554/107-1
00:21:44.063 --> 00:21:48.720
systems or perhaps to yourself a few
years ago to overcome some of the
808e9326-1751-4154-a778-cefeca685554/107-2
00:21:48.720 --> 00:21:53.837
technical challenges or technological
challenges that are involved in getting
808e9326-1751-4154-a778-cefeca685554/107-3
00:21:53.837 --> 00:21:56.264
to where Endeavor Health wants to be?
808e9326-1751-4154-a778-cefeca685554/108-0
00:21:57.624 --> 00:22:00.862
I think it's partnering with several
things.
808e9326-1751-4154-a778-cefeca685554/108-1
00:22:00.862 --> 00:22:05.828
I think that having an internal
partnership with your IT department,
808e9326-1751-4154-a778-cefeca685554/108-2
00:22:05.828 --> 00:22:09.067
right?
All of this is going to be ultimately
808e9326-1751-4154-a778-cefeca685554/108-3
00:22:09.067 --> 00:22:12.737
based on getting that data in an
efficient manner.
808e9326-1751-4154-a778-cefeca685554/108-4
00:22:12.737 --> 00:22:16.264
I think parallel processing.
So we're so used to
808e9326-1751-4154-a778-cefeca685554/109-0
00:22:16.584 --> 00:22:21.239
going from A to B to C,
but we want ABC to be happening all
808e9326-1751-4154-a778-cefeca685554/109-1
00:22:21.239 --> 00:22:25.351
simultaneously,
becoming efficient in how we look at
808e9326-1751-4154-a778-cefeca685554/109-2
00:22:25.351 --> 00:22:31.170
trials and getting them up and rolling.
The IRB should be working with the
808e9326-1751-4154-a778-cefeca685554/109-3
00:22:31.170 --> 00:22:37.144
compliance, which should be working.
So it all has to happen simultaneously.
808e9326-1751-4154-a778-cefeca685554/111-0
00:22:37.464 --> 00:22:40.728
and most places are, you know,
still sequential.
808e9326-1751-4154-a778-cefeca685554/111-1
00:22:40.728 --> 00:22:45.925
I think when it comes to data, again,
a lot of this is going to depend on the
808e9326-1751-4154-a778-cefeca685554/110-0
00:22:41.264 --> 00:22:41.744
Mmh.
808e9326-1751-4154-a778-cefeca685554/111-2
00:22:45.925 --> 00:22:51.121
type of study, but as you're alluding to,
we just have that complexity to get
808e9326-1751-4154-a778-cefeca685554/111-3
00:22:51.121 --> 00:22:55.118
images in, et cetera.
So establishing those secure sites to
808e9326-1751-4154-a778-cefeca685554/111-4
00:22:55.118 --> 00:22:56.984
protect patient information,
808e9326-1751-4154-a778-cefeca685554/112-0
00:22:57.304 --> 00:23:03.086
to get that information in a reliable way
that you can trust and that can be then
808e9326-1751-4154-a778-cefeca685554/112-1
00:23:03.086 --> 00:23:08.867
included in the studies is also important.
And that sounds simple, right? I mean,
808e9326-1751-4154-a778-cefeca685554/112-2
00:23:08.867 --> 00:23:12.534
these concepts are like, you got data,
you want it,
808e9326-1751-4154-a778-cefeca685554/112-3
00:23:12.534 --> 00:23:16.624
and we've got to bring that in.
But there's a lot of work
808e9326-1751-4154-a778-cefeca685554/113-0
00:23:16.904 --> 00:23:23.598
that has to go on behind the scenes and
foundation to make that happen. But again,
808e9326-1751-4154-a778-cefeca685554/113-1
00:23:23.598 --> 00:23:29.002
because clinical trials,
we don't want to increase risk to patient
808e9326-1751-4154-a778-cefeca685554/113-2
00:23:29.002 --> 00:23:33.761
and we want to limit that risk as much as
we possibly can.
808e9326-1751-4154-a778-cefeca685554/113-3
00:23:33.761 --> 00:23:36.584
And so one of those risks cannot be
808e9326-1751-4154-a778-cefeca685554/114-0
00:23:36.704 --> 00:23:42.091
that we leak that information outside or
that it was compromised in some fashion.
808e9326-1751-4154-a778-cefeca685554/114-1
00:23:42.091 --> 00:23:45.704
So having those necessary guardrails in
place is also.
808e9326-1751-4154-a778-cefeca685554/115-0
00:23:47.144 --> 00:23:49.330
Brian,
thank you so much for joining us today.
808e9326-1751-4154-a778-cefeca685554/115-1
00:23:49.330 --> 00:23:51.144
I really appreciate your participation.
808e9326-1751-4154-a778-cefeca685554/116-0
00:23:51.544 --> 00:23:52.584
Thank you, thank you.
808e9326-1751-4154-a778-cefeca685554/117-0
00:23:52.984 --> 00:23:56.662
And for our listeners,
this has been Brian Helfand at Endeavor
808e9326-1751-4154-a778-cefeca685554/117-1
00:23:56.662 --> 00:23:59.464
Health,
the Associate Chief Scientific Officer.
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.